The CVC HeartBeat: All the latest information about heart health and wellness from the experts at the University of Michigan Frankel Cardiovascular Center, nationally ranked for heart care by U.S. News & World Report. To make an appointment, call us at 1-888-287-1082.
University of Michigan cardiologist Dr. G. Michael Deeb wants his patients to know something: Nicotine is toxic not only to the lungs but also to the heart. “When most patients think of the dangers of smoking, they think about the lungs,” says Dr. Deeb. “But cardiovascular disease is the number one killer in Michigan, and smoking is accelerating the problem.”
According to theAmerican Heart Association, as many as 30 percent of all coronary heart disease deaths in the United States each year are attributable to cigarette smoking, and the more you smoke, the greater your risk. But even people who smoke fewer than five cigarettes a day can have early signs of cardiovascular disease.Continue reading →
A new app designed to monitor symptoms associated with atrial fibrillation, or Afib, is being evaluated as part of a University of Michigan study. Developed by U-M cardiologist Dr. Hamid Ghanbari, “miAfib” allows patients to more accurately communicate their atrial fibrillation symptoms in real time.
Tracking Afib sypmtoms
Atrial fibrillation is the most prevalent major arrhythmia in the United States. It can lead to an increased risk of stroke, congestive heart failure and overall mortality. What is much less certain, says Dr. Ghanbari, is the association between Afib symptoms, affect and heart rhythm on a daily basis.Continue reading →
The American Heart Association reports that while an estimated 10 percent of Americans ages 18 and older acknowledge depression, up to 33 percent of heart attack patients develop some degree of depression.
Dr. Michelle Riba, professor of psychiatry and associate chair for U-M’s Integrated Medical and Psychiatric Services in the Department of Psychiatry and associate director of the U-M Comprehensive Depression Center, takes it a step further: “It’s very complicated,” she says, noting that“almost every major cardiac condition has psychological issues that need to be addressed.” Monitoring a heart patient’s mental health is just as important as treating his or her physical condition, she says.
It gets even more complicated, says Dr. Riba, because not only can cardiovascular disease lead to depression, but also depression can lead to cardiovascular disease. “It’s bidirectional.”
Atrial fibrillation, or Afib, is the most commoncardiac arrhythmia, resulting in a fast or irregular heart rhythm among more than 5 million Americans. Afib is traditionally treated with blood-thinners or anticoagulants such as warfarin, but a new device, recently approved by the FDA, is changing the way Afib is treated.
The WATCHMAN™ Left Arial Appendage Closure Deviceoffers patients with non-valvular atrial fibrillation a potentially life-changing stroke risk treatment option that could free them from the challenges of long-term warfarin therapy.
The Frankel Cardiovascular Center is among the first heart centers in the nation to use the WATCHMAN Device. With stroke being one of the most feared consequences of Afib, the WATCHMAN Device has proved to be a viable alternative to blood-thinning medications, which are not well-tolerated by some patients and have a significant risk for bleeding complications.Continue reading →
The many symptoms of PAD include a cramping in the leg or calf muscles while walking.
Peripheral artery disease, or PAD, is a disease of the peripheral arteries, most commonly in the pelvis and legs, in which plaque builds up in the arteries that carry blood to your head, organs and limbs. Over time, plaque can harden and narrow the arteries, thus limiting the flow of oxygen-rich blood to your organs and other parts of your body.
The more you understand about the condition and symptoms, the more you’ll be able to protect your health. For example, diabetes often goes hand in hand with PAD, which results in a decrease of blood flow to the legs and feet. This can result in inadequate blood flow to heal a foot sore or wound.
Patients with diabetes and PAD are more likely to have healing complications, infection and, in the most extreme cases, amputation. Although having diabetes puts you at a greater risk of developing PAD, anyone can be diagnosed with the disease. According to the American Heart Association, those who smoke, have high blood pressure or high cholesterol are also at risk for PAD.
Heart failure is a debilitating and life-threatening condition affecting nearly six million people in the United States. In patients with heart failure, the heart cannot pump enough blood to meet the body’s nutrition and oxygen needs. The blood begins to back up and, as a result, the veins, tissues and lungs become congested with fluid.
Heart failure patients face a high risk of repeated hospitalizations and symptoms such as fatigue, loss of breath and fluid retention, all significantly impacting their quality of life. These patients also face the risk of death.
But now there’s a new heart failure drug, known as Entresto, bringing hope to many of these patients. Approval of Entresto came six weeks ahead of the FDA’s priority review action date, allowing it to be available to patients in the United States sooner than anticipated.Continue reading →
NOTICE: Except where otherwise noted, all articles are published under a Creative Commons Attribution 3.0 license. You are free to copy, distribute, adapt, transmit, or make commercial use of this work as long as you attribute the University of Michigan Health System as the original creator and include a link to this article.